ArticleJournal of the American Heart Association2025
Congenital Heart Defects and Apgar Score at Birth, a Nationwide Study.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Importance of Perinatal Follow-Up in the Management of Critical Congenital Heart Diseases: A Pediatric Heart Center Experience.Children (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLow Apgar scores have been associated with an increased risk of brain injury and neurodevelopmental disorders in newborns with congenital heart defects (CHDs). However, the relation between CHD subtypes and low Apgar scores remains unknown. This study aimed to assess the association between major subtypes of CHD and low (<7) Apgar scores at 5 minutes. METHODS AND
resultsThis population-based study included 1 040 474 liveborn singletons in Denmark from 1997 to 2013. The association between CHD and low Apgar scores was estimated by confounder-adjusted, multivariable logistic regression. In mediation analyses, the underlying mechanisms were examined. Low Apgar scores were present in 3.0% of newborns with CHD and in 0.7% of newborns without CHD. Overall, CHD was associated with an increased risk of a low Apgar score (adjusted odds ratio, 2.5 [95% CI, 2.1-3.0]). CHD subtypes associated with the highest risks were anomalous pulmonary venous return (adjusted odds ratio, 5.7 [95% CI, 2.2-14.9]), hypoplastic left heart syndrome (adjusted odds ratio, 5.1 [95% CI, 2.2-11.8]), and transposition of the great arteries (adjusted odds ratio, 3.5 [95% CI, 1.7-7.4]). In mediation analyses, preterm birth explained 25.2% (95% CI, 11.8-38.6) of the association between CHD and low Apgar scores.
conclusionsNearly all CHD subtypes were associated with an increased risk of a low Apgar score. The association was most pronounced in severe and potentially cyanotic types of CHD. These findings suggest that CHD is associated with a complicated fetal-to-neonatal transition and highlight the potential for improvements of this process in infants with CHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.